These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 20146365

  • 1. Inhaled versus systemic antibiotics and airway inflammation in children with cystic fibrosis and Pseudomonas.
    Noah TL, Ivins SS, Abode KA, Stewart PW, Michelson PH, Harris WT, Henry MM, Leigh MW.
    Pediatr Pulmonol; 2010 Mar; 45(3):281-90. PubMed ID: 20146365
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosis.
    Gibson RL, Emerson J, McNamara S, Burns JL, Rosenfeld M, Yunker A, Hamblett N, Accurso F, Dovey M, Hiatt P, Konstan MW, Moss R, Retsch-Bogart G, Wagener J, Waltz D, Wilmott R, Zeitlin PL, Ramsey B, Cystic Fibrosis Therapeutics Development Network Study Group.
    Am J Respir Crit Care Med; 2003 Mar 15; 167(6):841-9. PubMed ID: 12480612
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Use of inhaled tobramycin in patients with cystic fibrosis].
    Chermenskiĭ AG, Gembitskaia TE.
    Ter Arkh; 2010 Mar 15; 82(8):76-8. PubMed ID: 20873251
    [Abstract] [Full Text] [Related]

  • 7. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience.
    Hansen CR, Pressler T, Høiby N.
    J Cyst Fibros; 2008 Nov 15; 7(6):523-30. PubMed ID: 18693078
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Long-term daily high and low doses of azithromycin in children with cystic fibrosis: a randomized controlled trial.
    Kabra SK, Pawaiya R, Lodha R, Kapil A, Kabra M, Vani AS, Agarwal G, Shastri SS.
    J Cyst Fibros; 2010 Jan 15; 9(1):17-23. PubMed ID: 19818694
    [Abstract] [Full Text] [Related]

  • 12. Eradication of initial Pseudomonas aeruginosa colonization in patients with cystic fibrosis.
    Griese M, Müller I, Reinhardt D.
    Eur J Med Res; 2002 Feb 21; 7(2):79-80. PubMed ID: 11891148
    [Abstract] [Full Text] [Related]

  • 13. Distinct patterns of inflammation in the airway lumen and bronchial mucosa of children with cystic fibrosis.
    Regamey N, Tsartsali L, Hilliard TN, Fuchs O, Tan HL, Zhu J, Qiu YS, Alton EW, Jeffery PK, Bush A, Davies JC.
    Thorax; 2012 Feb 21; 67(2):164-70. PubMed ID: 22008188
    [Abstract] [Full Text] [Related]

  • 14. Intravenous versus oral antibiotics for eradication of Pseudomonas aeruginosa in cystic fibrosis (TORPEDO-CF): a randomised controlled trial.
    Hewer SCL, Smyth AR, Brown M, Jones AP, Hickey H, Kenna D, Ashby D, Thompson A, Williamson PR, TORPEDO-CF study group.
    Lancet Respir Med; 2020 Oct 21; 8(10):975-986. PubMed ID: 33007285
    [Abstract] [Full Text] [Related]

  • 15. Inhaled colistin for the treatment of tracheobronchitis and pneumonia in critically ill children without cystic fibrosis.
    Falagas ME, Sideri G, Korbila IP, Vouloumanou EK, Papadatos JH, Kafetzis DA.
    Pediatr Pulmonol; 2010 Nov 21; 45(11):1135-40. PubMed ID: 20658485
    [Abstract] [Full Text] [Related]

  • 16. [Comparison of the pharmacokinetics of tobramycin administered in a single daily dose or in 3 doses in cystic fibrosis].
    Canis F, Trivier D, Vic P, Ategbo S, Turck D, Husson MO.
    Pathol Biol (Paris); 1998 Jun 21; 46(6):449-51. PubMed ID: 9769880
    [Abstract] [Full Text] [Related]

  • 17. Validation of the Treatment Satisfaction Questionnaire for Medication in patients with cystic fibrosis.
    Regnault A, Balp MM, Kulich K, Viala-Danten M.
    J Cyst Fibros; 2012 Dec 21; 11(6):494-501. PubMed ID: 22583743
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden.
    Knudsen PK, Olesen HV, Høiby N, Johannesson M, Karpati F, Laerum BN, Meyer P, Pressler T, Lindblad A, Scandinavian CF Study Consortium (SCFSC).
    J Cyst Fibros; 2009 Mar 21; 8(2):135-42. PubMed ID: 19157995
    [Abstract] [Full Text] [Related]

  • 20. Patient-specific modeling of regional antibiotic concentration levels in airways of patients with cystic fibrosis: are we dosing high enough?
    Bos AC, van Holsbeke C, de Backer JW, van Westreenen M, Janssens HM, Vos WG, Tiddens HA.
    PLoS One; 2015 Mar 21; 10(3):e0118454. PubMed ID: 25734630
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.